Glatopa is the first FDA-approved substitutable generic of Copaxone® (glatiramer acetate injection) 20 mg/mL for the treatment of patients with relapsing-forms of multiple sclerosis.1-4

Therapeutic Equivalence

C_to_the_G_522

Glatopa is an FDA approved, AP-rated, substitutable generic glatiramer acetate that is therapeutically equivalent to Copaxone® 20 mg/mL1-5:

  • Contains the same active ingredient
  • Same indication
  • Is identical in strength, dosage and route of administration
  • Meets the same requirements for safety and efficacy, purity and quality
  • Demonstrates no observable differences in physiochemical, biological or immunological properties

Chart_Camparison_500

*Glatopa 20 mg/mL dose is not interchangeable with glatiramer acetate 40 mg/mL dose.
Demonstrated equivalence to Copaxone® 20 mg/mL.1,2

Glatopa is therapeutically equivalent to Copaxone® 20 mg/mL, with FREE ongoing, individualized patient support services from Sandoz, a Novartis Division.

Please see full Prescribing Information for Glatopa.

 

Related content

Enroll Now

GlatopaCare_219

Encourage your patients to enroll in GlatopaCare® for individualized support services. 1.855.GLATOPA (1.855.452.8672).